Dr. Miguel HUESO

Nephrologist (MD) in the Dialysis Unit (Hospital Bellvitge), Ph.D. (UB, 2006), B.Sc. in Biochemistry (UB, 2011), and member of the Research Group in Nephrology (IDIBELL) and of BigData and Artificial Intelligence (Spanish Society of Nephrology). He has wide experience in Genetics and Molecular Biology (Fundació Pi i Sunyer, Fundació Catalana de Trasplantament and Juan de la Cierva postdoctoral research grant). He is leading a lab devoted to immunomodulation and the study of the molecular mechanisms of vascular injury in patients with CKD. Using experimental models of atherosclerosis, he identified some miRNAs involved in the regulation of the NF-kB pathway. In renal patients, he studied some biomarkers of cardiovascular events, the role of dialysis techniques in the activation of inflammation, and the impact of CKD on the outcome after cardiac surgery. Currently, he focuses his interest on the role of lncRNAs as microRNA "sponges", nanotechnology, and the application of Artificial Intelligence to Hemodialysis.